Rennova Health, Inc. RNVA
OTC PK
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Net Income | -- | 283.90K | -219.90K | -3.29M | -5.02M |
| Total Depreciation and Amortization | -- | 329.40K | 446.60K | 469.30K | 481.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | -1.26M | -1.18M | -955.80K | -316.80K |
| Change in Net Operating Assets | -- | 2.78M | 3.02M | 3.56M | 462.50K |
| Cash from Operations | -- | 2.13M | 2.07M | -218.40K | -4.39M |
| Capital Expenditure | -- | -221.80K | -255.70K | -35.20K | -34.80K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -754.90K | -1.06M | -869.90K | -722.90K |
| Cash from Investing | -- | -976.70K | -1.31M | -905.30K | -757.80K |
| Total Debt Issued | -- | 1.07M | 1.38M | 1.55M | 900.00K |
| Total Debt Repaid | -- | -2.01M | -2.25M | -1.75M | -2.09M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | 0.00 | 0.00 | 0.00 | 0.00 |
| Issuance of Preferred Stock | -- | 0.00 | 500.00K | 1.50M | 5.50M |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -86.30K | -245.10K | -403.90K | 512.50K |
| Cash from Financing | -- | -1.03M | -614.50K | 898.40K | 4.83M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | 124.40K | 148.00K | -225.00K | -320.50K |